메뉴 건너뛰기




Volumn 117, Issue 9, 2009, Pages 644-650

Estrogen receptor β- An independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?

Author keywords

Breast cancer; Estrogen receptor; Mammography screening; Progesterone receptor; Survival analysis

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; TAMOXIFEN;

EID: 69449101584     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02510.x     Document Type: Article
Times cited : (24)

References (31)
  • 1
    • 33645513485 scopus 로고    scopus 로고
    • Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: Follow-up study
    • Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006 332 : 689 692.
    • (2006) BMJ , vol.332 , pp. 689-692
    • Zackrisson, S.1    Andersson, I.2    Janzon, L.3    Manjer, J.4    Garne, J.P.5
  • 2
    • 33645498004 scopus 로고    scopus 로고
    • Ramifications of screening for breast cancer: Definition of overdiagnosis is confusing in follow-up of Malmo trial
    • Zahl PH, Maehlen J. Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmo trial. BMJ 2006 332 : 727 728.
    • (2006) BMJ , vol.332 , pp. 727-728
    • Zahl, P.H.1    Maehlen, J.2
  • 3
    • 4344689012 scopus 로고    scopus 로고
    • Risk for distant recurrence of breast cancer detected by mammography screening or other methods
    • Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004 292 : 1064 1073.
    • (2004) JAMA , vol.292 , pp. 1064-1073
    • Joensuu, H.1    Lehtimaki, T.2    Holli, K.3    Elomaa, L.4    Turpeenniemi-Hujanen, T.5    Kataja, V.6
  • 4
    • 23844500059 scopus 로고    scopus 로고
    • Role of detection method in predicting breast cancer survival: Analysis of randomized screening trials
    • Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005 97 : 1195 1203.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1195-1203
    • Shen, Y.1    Yang, Y.2    Inoue, L.Y.3    Munsell, M.F.4    Miller, A.B.5    Berry, D.A.6
  • 5
    • 4344674096 scopus 로고    scopus 로고
    • Do tumors detected by mammography screening have a favorable prognosis?
    • O'Regan RM. Do tumors detected by mammography screening have a favorable prognosis? JAMA 2004 292 : 1062 1063.
    • (2004) JAMA , vol.292 , pp. 1062-1063
    • O'Regan, R.M.1
  • 6
    • 23844557872 scopus 로고    scopus 로고
    • Should screen-detected breast cancers be managed differently?
    • Krzyzanowska MK, Tannock IF. Should screen-detected breast cancers be managed differently? J Natl Cancer Inst 2005 97 : 1170 1171.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1170-1171
    • Krzyzanowska, M.K.1    Tannock, I.F.2
  • 7
    • 0033833676 scopus 로고    scopus 로고
    • The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: A review
    • Girdler F, Brotherick I. The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: a review. Breast 2000 9 : 194 200.
    • (2000) Breast , vol.9 , pp. 194-200
    • Girdler, F.1    Brotherick, I.2
  • 9
    • 4944246588 scopus 로고    scopus 로고
    • Loss of ERbeta expression as a common step in estrogen-dependent tumor progression
    • Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004 11 : 537 551.
    • (2004) Endocr Relat Cancer , vol.11 , pp. 537-551
    • Bardin, A.1    Boulle, N.2    Lazennec, G.3    Vignon, F.4    Pujol, P.5
  • 10
    • 0037314762 scopus 로고    scopus 로고
    • Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice
    • Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol 2003 17 : 203 208.
    • (2003) Mol Endocrinol , vol.17 , pp. 203-208
    • Lindberg, M.K.1    Moverare, S.2    Skrtic, S.3    Gao, H.4    Dahlman-Wright, K.5    Gustafsson, J.A.6
  • 11
    • 0035952371 scopus 로고    scopus 로고
    • Clinical value of the wild-type estrogen receptor beta expression in breast cancer
    • Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, et al. Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett 2001 163 : 207 212.
    • (2001) Cancer Lett , vol.163 , pp. 207-212
    • Omoto, Y.1    Inoue, S.2    Ogawa, S.3    Toyama, T.4    Yamashita, H.5    Muramatsu, M.6
  • 12
    • 0036161026 scopus 로고    scopus 로고
    • Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers
    • Omoto Y, Kobayashi S, Inoue S, Ogawa S, Toyama T, Yamashita H, et al. Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur J Cancer 2002 38 : 380 386.
    • (2002) Eur J Cancer , vol.38 , pp. 380-386
    • Omoto, Y.1    Kobayashi, S.2    Inoue, S.3    Ogawa, S.4    Toyama, T.5    Yamashita, H.6
  • 14
    • 9144269004 scopus 로고    scopus 로고
    • Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer
    • Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, O'Higgins NJ, et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. Br J Cancer 2004 91 : 1687 1693.
    • (2004) Br J Cancer , vol.91 , pp. 1687-1693
    • Myers, E.1    Fleming, F.J.2    Crotty, T.B.3    Kelly, G.4    McDermott, E.W.5    O'Higgins, N.J.6
  • 17
    • 0018614399 scopus 로고
    • Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: Relation to oestradiol and progesterone cytosol receptors
    • Thorsen T. Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors. J Steroid Biochem 1979 10 : 661 668.
    • (1979) J Steroid Biochem , vol.10 , pp. 661-668
    • Thorsen, T.1
  • 18
    • 0019970517 scopus 로고
    • Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis
    • Maehle BO, Thoresen S, Skjaerven R, Hartveit F. Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis. Br J Cancer 1982 46 : 95 100.
    • (1982) Br J Cancer , vol.46 , pp. 95-100
    • Maehle, B.O.1    Thoresen, S.2    Skjaerven, R.3    Hartveit, F.4
  • 19
    • 0030659080 scopus 로고    scopus 로고
    • Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma
    • Straume O, Akslen LA. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 1997 74 : 535 539.
    • (1997) Int J Cancer , vol.74 , pp. 535-539
    • Straume, O.1    Akslen, L.A.2
  • 20
    • 2142760943 scopus 로고    scopus 로고
    • Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer
    • Stefansson IM, Salvesen HB, Akslen LA. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J Clin Oncol 2004 22 : 1242 1252.
    • (2004) J Clin Oncol , vol.22 , pp. 1242-1252
    • Stefansson, I.M.1    Salvesen, H.B.2    Akslen, L.A.3
  • 21
    • 0030801841 scopus 로고    scopus 로고
    • Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
    • Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997 277 : 1508 1510.
    • (1997) Science , vol.277 , pp. 1508-1510
    • Paech, K.1    Webb, P.2    Kuiper, G.G.3    Nilsson, S.4    Gustafsson, J.5    Kushner, P.J.6
  • 22
    • 3242720708 scopus 로고    scopus 로고
    • Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: The Greek experience
    • Stefanou D, Batistatou A, Briasoulis E, Arkoumani E, Agnantis NJ. Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experience. Eur J Gynaecol Oncol 2004 25 : 457 461.
    • (2004) Eur J Gynaecol Oncol , vol.25 , pp. 457-461
    • Stefanou, D.1    Batistatou, A.2    Briasoulis, E.3    Arkoumani, E.4    Agnantis, N.J.5
  • 23
    • 0038160964 scopus 로고    scopus 로고
    • Expression of estrogen receptor-beta in normal mammary and tumor tissues: Is it protective in breast carcinogenesis?
    • Park BW, Kim KS, Heo MK, Ko SS, Hong SW, Yang WI, et al. Expression of estrogen receptor-beta in normal mammary and tumor tissues: is it protective in breast carcinogenesis? Breast Cancer Res Treat 2003 80 : 79 85.
    • (2003) Breast Cancer Res Treat , vol.80 , pp. 79-85
    • Park, B.W.1    Kim, K.S.2    Heo, M.K.3    Ko, S.S.4    Hong, S.W.5    Yang, W.I.6
  • 24
    • 0038579655 scopus 로고    scopus 로고
    • Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation
    • Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003 39 : 1251 1258.
    • (2003) Eur J Cancer , vol.39 , pp. 1251-1258
    • Konstantinopoulos, P.A.1    Kominea, A.2    Vandoros, G.3    Sykiotis, G.P.4    Andricopoulos, P.5    Varakis, I.6
  • 25
    • 0032401855 scopus 로고    scopus 로고
    • Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis
    • Pujol P, Rey JM, Nirde P, Roger P, Gastaldi M, Laffargue F, et al. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 1998 58 : 5367 5373.
    • (1998) Cancer Res , vol.58 , pp. 5367-5373
    • Pujol, P.1    Rey, J.M.2    Nirde, P.3    Roger, P.4    Gastaldi, M.5    Laffargue, F.6
  • 27
    • 0033231027 scopus 로고    scopus 로고
    • Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients
    • Speirs V, Malone C, Walton DS, Kerin MJ, Atkin SL. Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 1999 59 : 5421 5424.
    • (1999) Cancer Res , vol.59 , pp. 5421-5424
    • Speirs, V.1    Malone, C.2    Walton, D.S.3    Kerin, M.J.4    Atkin, S.L.5
  • 28
    • 33748305646 scopus 로고    scopus 로고
    • Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours
    • Skliris GP, Leygue E, Curtis-Snell L, Watson PH, Murphy LC. Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer 2006 95 : 616 626.
    • (2006) Br J Cancer , vol.95 , pp. 616-626
    • Skliris, G.P.1    Leygue, E.2    Curtis-Snell, L.3    Watson, P.H.4    Murphy, L.C.5
  • 30
    • 34248159369 scopus 로고    scopus 로고
    • Lymph node status as a guide to selection of available prognostic markers in breast cancer: The clinical practice of the future?
    • Elzagheid A, Kuopio T, Pyrhonen S, Collan Y. Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future? Diagn Pathol 2006 1 : 41.
    • (2006) Diagn Pathol , vol.1 , pp. 41
    • Elzagheid, A.1    Kuopio, T.2    Pyrhonen, S.3    Collan, Y.4
  • 31
    • 1942542421 scopus 로고    scopus 로고
    • Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study
    • Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004 328 : 921 924.
    • (2004) BMJ , vol.328 , pp. 921-924
    • Zahl, P.H.1    Strand, B.H.2    Maehlen, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.